Multiplex Assays Market by Type (Protein [Bead, Planar], Nucleic Acid, Cell) Technology (Flow Cytometry, PCR, Immunoassay) Application (R&D, Diagnosis (Oncology, Cardiovascular, Infectious, Autoimmune Diseases) Product, End User

The global multiplex assays market is expected to reach $6.24 billion by 2030 at a CAGR of 9.0% from 2023 to 2030.

Succeeding extensive secondary and primary research and in-depth analysis of the market scenario, the report comprises the analysis of key industry drivers, restraints, challenges, and opportunities. The growth of this market is attributed to several factors, the advantages of multiplex assays over singleplex assays, the use of multiplexing in companion diagnostics, the increasing prevalence of chronic and infectious diseases, and rising awareness about the importance of early disease diagnosis. However, the high costs of multiplex assay equipment restrain the growth of this market.

The growing need for high-throughput and automated laboratory systems and the increasing focus on personalized medicine is expected to generate growth opportunities for the players operating in this market. However, the shortage of skilled professionals and the risk of cross-reactivity are major challenges to market growth.

Among all the types studied in this report, in 2023 protein multiplex assays segment is expected to account for the largest share of the multiplex assays market. Protein multiplex assays are further segmented into bead-based assays and planar assays. In 2023, the bead-based assays segment is expected to account for the largest share of the protein multiplex assays market. Multiplex bead-based assays have become essential tools for diagnosing various diseases. These assays are used for testing allergies, cancer markers, cytokines, cardiac markers, autoimmune diseases, and endocrine diseases. Bead-based assays offer a dynamic range of analytes as they are measured using flow cytometry. They are suitable for high-throughput analysis and are much more rapid, making them the preferred alternative to planar assays.

Among all the products studied in this report, in 2023, the consumables segment is expected to account for the largest share of the multiplex assays market. The large market share of this segment is attributed to the repetitive use of kits, the growing portfolio of disease-specific kits for early diagnosis of diseases, and the increasing product approvals. The continuous advancements in reagents and kits, the development of user-friendly diagnostic kits, and the adoption of multiplex assay kits in clinical and research laboratories positively impact the demand for consumables used in multiplex assays.

Among all the technologies studied in this report, the flow cytometry segment is projected to register the highest CAGR during the forecast period. Flow cytometry is considered an important tool in clinical diagnosis and research & development. It provides a multiparametric analysis of many single cells, which can be used in multiple research areas. Additionally, market players are launching advanced flow cytometers to support growing market needs. For instance, in June 2023, Becton, Dickinson and Company (U.S.) launched a BD FACSDuet to automate sample preparation during clinical flow cytometry diagnostics.

Among all the applications studied in this report, in 2023, the research & development segment is expected to account for the largest share of the multiplex assays market. The large market share of this segment is attributed to increasing applications of multiplex assays in drug discovery, biomarker profiling, and understanding disease mechanisms. The demand for multiplex assays in research & development is increasing rapidly and is also contributing to the largest share of the segment.

Among all the end users studied in this report, the research & development segment is expected to grow at the highest CAGR during the forecast period. The highest CAGR of this segment is attributed to factors such as the increasing R&D investments by pharmaceutical & biotechnology companies, the widespread utilization of multiplex assays in drug discovery & development, and a growing emphasis on personalized medicine research. The rising spending on R&D by pharmaceutical companies is also contributing to the largest share of this segment.

An in-depth analysis of the geographical scenario of the global multiplex assays market provides detailed qualitative and quantitative insights about the five major geographies (North America, Europe, Asia-Pacific, Latin America, and the Middle East & Africa) along with the coverage of major countries in each region. In 2023, North America is expected to account for the largest share of the multiplex assays market, followed by Europe, Asia-Pacific, Latin America, and the Middle East & Africa. North America’s large share is attributed to the region’s high R&D spending by the pharmaceutical & biotechnology companies for the development of drugs and biomarker identification, increasing prevalence of chronic diseases, rising healthcare expenditure, presence of leading market players in the region, and favorable government initiatives for research & development. According to the U.S. Congressional Budget Office, U.S. pharmaceutical R&D expenditure increased from 91.1 billion in 2020 to 102.3 billion in 2021.

The report offers a competitive landscape based on an extensive assessment of the product portfolio offerings, geographic presences, and key strategic developments adopted by leading market players in the industry over the years (2020-2023). The key players operating in the global multiplex assays market are Thermo Fisher Scientific, Inc. (U.S.), Bio-Rad Laboratories, Inc. (U.S.), Seegene, Inc. (South Korea), Qiagen N.V. (Netherlands), PerkinElmer, Inc. (U.S.), F. Hoffmann-La Roche Ltd. (Switzerland), Agilent Technologies, Inc. (U.S.), Abbott Laboratories (U.S.), Siemens Healthineers AG (Germany), Illumina, Inc. (U.S.), Becton, Dickinson and Company (U.S.), Quanterix Corporation (U.S.), DiaSorin S.p.A. (Italy), and Merck KGaA (Germany).

Scope of the Report:

Multiplex Assays Market Assessment, by Type

Protein Multiplex Assays
Bead-based Assays
Planar Assay
Nucleic Acid Multiplex Assays
Cell-based Multiplex Assays

Multiplex Assays Market Assessment, by Product

Consumables
Instruments
Software & Services

Multiplex Assays Market Assessment, by Technology

Flow Cytometry
Multiplex Immunoassay
Multiplex Real-Time PCR
Sequencing
Other Technologies

Note: Other technologies consist of microarray and immunohistochemistry

Multiplex Assays Market Assessment, by Application

Research & Development
Clinical Diagnosis
Infectious Diseases
Oncology
Cardiovascular Diseases
Autoimmune Diseases
Other Diseases

Note: Other diseases include neurological diseases, thrombosis, and drug abuse testing

Multiplex Assays Market Assessment, by End User

Pharmaceutical & Biotechnology Companies
Diagnostic Laboratories
Hospitals
Other End Users

Note: Other end users consist of academic institutes & research centers, forensic labs, agriculture companies, and food & beverage companies

Multiplex Assays Market Assessment, by Geography

North America

U.S
Canada

Europe

Germany
U.K.
France
Italy
Spain
Rest of Europe (Roe)

Asia-Pacific (APAC)

China
Japan
India
Rest of Asia-Pacific (RoAPAC)

Latin America

Brazil
Mexico
Rest of Latin America (RoLATAM)

Middle East & Africa

1. Introduction

1.1. Market Definition
1.2. Market Ecosystem
1.3. Currency And Limitations
1.4. Key stakeholders

2. Research Methodology

2.1. Research Approach
2.2. Process of Data Collection and Validation
2.2.1. Secondary Research
2.2.2. Primary Research/Interviews with Key Opinion Leaders of the Industry
2.3. Market Sizing and Forecasting
2.3.1. Market Size Estimation Approach
2.3.2. Growth Forecast Approach
2.4. Assumptions for the study

3. Executive Summary

4. Market Insights

4.1. Overview
4.2. Factors Affecting Market Growth
4.2.1. Market Dynamics
4.2.1.1. Advantages of Multiplex Assays over Singleplex Assays Leading to Their Increased Adoption
4.2.1.2. Growing Use of Multiplexing in Companion Diagnostics Driving the Demand for Multiplex Assays
4.2.1.3. High Costs of Multiplex Assay Equipment Hampering Adoption Among End Users
4.2.1.4. Increasing Focus on Personalized Medicine Boosting the Utilization of Multiplex Assays
4.2.1.5. Shortage of Skilled Professionals and the Risk of Cross-reactivity Limiting the Adoption of Multiplex Assays
4.2.2. Factor Analysis
4.3. Technology Trends
4.3.1. Technological Advancements in Multiplex PCR Technology
4.3.2. Integration of Artificial Intelligence and Machine Learning into Multiplex Assay Systems
4.3.3. Development of Smartphone-based Diagnostic Testing Platforms
4.4. Regulatory Analysis
4.4.1. North America
4.4.1.1. U.S.
4.4.1.2. Canada
4.4.2. Europe
4.4.3. Asia-Pacific
4.4.3.1. China
4.4.3.2. India
4.4.3.3. Japan
4.4.3.4. South Korea
4.4.4. Latin America
4.4.5. Middle East & Africa
4.5. Pricing Analysis
4.6. Porter’s Five Forces Analysis
4.6.1. Bargaining Power of Suppliers
4.6.2. Bargaining Power of Buyers
4.6.3. Threat of Substitutes
4.6.4. Threat of New Entrants
4.6.5. Degree of Competition

5. Multiplex Assays Market Assessment-by Type

5.1. Overview
5.2. Protein Multiplex Assays
5.2.1. Bead-based Assays
5.2.2. Planar Assays
5.3. Nucleic Acid Multiplex Assays
5.4. Cell-based Multiplex Assays

6. Multiplex Assays Market Assessment- by Product

6.1. Overview
6.2. Consumables
6.3. Instruments
6.4. Software & Services

7. Multiplex Assays Market Assessment- by Technology

7.1. Overview
7.2. Flow Cytometry
7.3. Multiplex Immunoassay
7.4. Multiplex Real-time PCR
7.5. Sequencing
7.6. Other Technologies

8. Multiplex Assays Market Assessment- by Application

8.1. Overview
8.2. Research & Development
8.3. Clinical Diagnosis
8.3.1. Infectious Diseases
8.3.2. Oncology
8.3.3. Cardiovascular Diseases
8.3.4. Autoimmune Diseases
8.3.5. Other Diseases

9. Multiplex Assays Market Assessment- by End User

9.1. Overview
9.2. Pharmaceutical & Biotechnology Companies
9.3. Diagnostic Laboratories
9.4. Hospitals
9.5. Other End Users

10. Multiplex Assays Market Assessment-by Geography

10.1. Overview
10.2. North America
10.2.1. U.S.
10.2.2. Canada
10.3. Europe
10.3.1. Germany
10.3.2. France
10.3.3. U.K.
10.3.4. Italy
10.3.5. Spain
10.3.6. Rest of Europe
10.4. Asia-Pacific
10.4.1. China
10.4.2. Japan
10.4.3. India
10.4.4. Rest of Asia-Pacific
10.5. Latin America
10.5.1. Brazil
10.5.2. Mexico
10.5.3. Rest of Latin America
10.6. Middle East & Africa

11. Competition Analysis

11.1. Overview
11.2. Key Growth Strategies
11.3. Competitive Benchmarking
11.4. Competitive Dashboard
11.4.1. Industry Leaders
11.4.2. Differentiators
11.4.3. Vanguards
11.4.4. Emerging Companies

12. Company Profiles (Company Overview, Financial Snapshot, Product Portfolio, and Strategic Developments)

12.1. Seegene, Inc.
12.2. F. Hoffmann-La Roche Ltd.
12.3. Thermo Fisher Scientific, Inc.
12.4. Illumina, Inc.
12.5. QIAGEN N.V.
12.6. Becton, Dickinson and Company
12.7. Bio-Rad Laboratories, Inc.
12.8. DiaSorin S.p.A.
12.9. PerkinElmer, Inc.
12.10. Agilent Technologies, Inc.
12.11. Abbott Laboratories
12.12. Siemens Healthineers AG
12.13. Merck KGaA
12.14. Quanterix Corporation
(Note: SWOT analysis is provided for the top 5 companies)

13. Appendix

13.1. Available Customization
13.2. Related Reports

List of Tables

Table 1: Estimated Number of New Cancer Cases, by Type (2020 Vs. 2030)
Table 2: Some of The Emergency Use Authorizations (EUA) Granted for Multiplex Assays During the Covid-19 Pandemic
Table 3: Medical Devices Regulatory Authorities in the Rest of APAC Countries
Table 4: IVD Regulatory Systems, by Country
Table 5: Average Selling Price of Multiplex Assays Products (Price/ USD)
Table 6: Thermo Fisher Scientific, Inc. (U.S.): Multiplex Assays Prices
Table 7: R&D Systems (U.S.): Multiplex Assays Prices
Table 8: Quanterix Corporation (U.S.): Multiplex Assays Prices
Table 9: Global Multiplex Assays Market, by Type, 2021- 2030 (USD Million)
Table 10: Global Protein Multiplex Assays Market, by Type, 2021- 2030 (USD Million)
Table 11: Global Protein Multiplex Assays Market, by Country/Region, 2021- 2030 (USD Million)
Table 12: Global Multiplex Assays Market for Bead-based Assays, by Country/Region, 2021- 2030 (USD Million)
Table 13: Global Multiplex Assays Market for Planar Assays, by Country/Region, 2021-2030 (USD Million):
Table 14: Global Multiplex Assays Market for Nucleic Acid Multiplex Assays, by Country/Region, 2021-2030 (USD Million):
Table 15: Global Multiplex Assays Market for Cell-Based Multiplex Assays, by Country/Region, 2021-2030 (USD Million):
Table 16: Global Multiplex Assays Market, by Product, 2021- 2030 (USD Million)
Table 17: Key Companies Offering Consumables for Multiplex Assays
Table 18: Global Multiplex Assays Market for Consumables, by Country/Region, 2021-2030 (USD Million):
Table 19: Global Multiplex Assays Market for Instruments, by Country/Region, 2021-2030 (USD Million)
Table 20: Key Companies Offering Software
Table 21: Global Multiplex Assays Market for Software & Services, by Country/Region, 2021-2030 (USD Million)
Table 22: Global Multiplex Assays Market, by Technology, 2021- 2030 (USD Million)
Table 23: Global Multiplex Assays Market for Flow Cytometry, by Country/Region, 2021-2030 (USD Million):
Table 24: Global Multiplex Assays Market for Multiplex Immunoassay, by Country/Region, 2021-2030 (USD Million)
Table 25: Global Multiplex Assays Market for Multiplex Real-Time PCR, by Country/Region, 2021-2030 (USD Million)
Table 26: Global Multiplex Assays Market for Sequencing, by Country/Region, 2021-2030 (USD Million)
Table 27: Global Multiplex Assays Market for Other Technologies, by Country/Region, 2021-2030 (USD Million)
Table 28: Global Multiplex Assays Market, by Application, 2021- 2030 (USD Million)
Table 29: Global Multiplex Assays Market for Research & Development, by Country/Region, 2021-2030 (USD Million):
Table 30: Global Multiplex Assays Market for Clinical Diagnosis, by Type, 2021-2030 (USD Million)
Table 31: Global Multiplex Assays Market for Clinical Diagnosis, by Country/Region, 2021-2030 (USD Million)
Table 32: COVID-19 Testing Kits
Table 33: Global Multiplex Assays Market for Infectious Diseases, by Country/Region, 2021-2030 (USD Million)
Table 34: Global Multiplex Assays Market for Oncology, by Country/Region, 2021-2030 (USD Million)
Table 35: Global Multiplex Assays Market for Cardiovascular Diseases,: by Country/Region, 2021-2030 (USD Million):
Table 36: Global Multiplex Assays Market, For Autoimmune Diseases, by Country/Region, 2021-2030 (USD Million)
Table 37: Global Multiplex Assays Market for Other Diseases, by Country/Region, 2021-2030 (USD Million):
Table 38: Global Multiplex Assays Market, by End User, 2021- 2030 (USD Million)
Table 39: Global Multiplex Assays Market for Pharmaceutical & Biotechnology Companies, by Country/Region, 2021-2030 (USD Million)
Table 40: Global Multiplex Assays Market for Diagnostic Laboratories, by Country/Region, 2021-2030 (USD Million):
Table 41: Global Multiplex Assays Market for Hospitals, by Country/Region, 2021-2030 (USD Million)
Table 42: Global Multiplex Assays Market for Other End Users, by Country/Region, 2021-2030 (USD Million)
Table 43: Global Multiplex Assays Market, by Country/Region, 2021- 2030 (USD Million)
Table 44: North America: Multiplex Assays Market, by Country, 2021-2030 (USD Million)
Table 45: North America: Multiplex Assays Market, by Type, 2021-2030 (USD Million)
Table 46: North America: Protein Multiplex Assays Market, by Type, 2021-2030 (USD Million)
Table 47: North America: Multiplex Assays Market, by Product, 2021-2030 (USD Million)
Table 48: North America: Multiplex Assays Market, by Technology, 2021-2030 (USD Million)
Table 49: North America: Multiplex Assays Market, by Application, 2021-2030 (USD Million)
Table 50: North America: Multiplex Assays Market for Clinical Diagnosis Application, by Type, 2021-2030 (USD Million):
Table 51: North America: Multiplex Assays Market, by End User, 2021-2030 (USD Million)
Table 52: U.S.: Multiplex Assays Market, by Type, 2021-2030 (USD Million)
Table 53: U.S.: Protein Multiplex Assays Market, by Type, 2021-2030 (USD Million)
Table 54: U.S.: Multiplex Assays Market, by Product, 2021-2030 (USD Million)
Table 55: U.S.: Multiplex Assays Market, by Technology, 2021-2030 (USD Million)
Table 56: U.S.: Multiplex Assays Market, by Application, 2021-2030 (USD Million)
Table 57: U.S.: Multiplex Assays Market for Clinical Diagnosis Application, by Type, 2021-2030 (USD Million):
Table 58: U.S.: Multiplex Assays Market, by End User, 2021-2030 (USD Million)
Table 59: Canada: Multiplex Assays Market, by Type, 2021-2030 (USD Million)
Table 60: Canada: Protein Multiplex Assays Market, by Type, 2021-2030 (USD Million)
Table 61: Canada: Multiplex Assays Market, by Product, 2021-2030 (USD Million)
Table 62: Canada: Multiplex Assays Market, by Technology, 2021-2030 (USD Million)
Table 63: Canada: Multiplex Assays Market, by Application, 2021-2030 (USD Million)
Table 64: Canada: Multiplex Assays Market for Clinical Diagnosis Application, by Type, 2021-2030 (USD Million):
Table 65: Canada: Multiplex Assays Market, by End User, 2021-2030 (USD Million)
Table 66: Europe: Multiplex Assays Market, by Country/Region, 2021-2030 (USD Million)
Table 67: Europe: Multiplex Assays Market, by Type, 2021-2030 (USD Million)
Table 68: Europe: Protein Multiplex Assays Market, by Type, 2021-2030 (USD Million)
Table 69: Europe: Multiplex Assays Market, by Product, 2021-2030 (USD Million)
Table 70: Europe: Multiplex Assays Market, by Technology, 2021-2030 (USD Million)
Table 71: Europe: Multiplex Assays Market, by Application, 2021-2030 (USD Million)
Table 72: Europe: Multiplex Assays Market for Clinical Diagnosis Application, by Type, 2021-2030 (USD Million)
Table 73: Europe: Multiplex Assays Market, by End User, 2021-2030 (USD Million)
Table 74: Germany: Multiplex Assays Market, by Type, 2021-2030 (USD Million)
Table 75: Germany: Protein Multiplex Assays Market, by Type, 2021-2030 (USD Million)
Table 76: Germany: Multiplex Assays Market, by Product, 2021-2030 (USD Million)
Table 77: Germany: Multiplex Assays Market, by Technology, 2021-2030 (USD Million)
Table 78: Germany: Multiplex Assays Market, by Application, 2021-2030 (USD Million)
Table 79: Germany: Multiplex Assays Market for Clinical Diagnosis Application,: by Type, 2021-2030 (USD Million):
Table 80: Germany: Multiplex Assays Market, by End User, 2021-2030 (USD Million)
Table 81: France: Multiplex Assays Market, by Type, 2021-2030 (USD Million)
Table 82: France: Protein Multiplex Assays Market, by Type, 2021-2030 (USD Million)
Table 83: France: Multiplex Assays Market, by Product, 2021-2030 (USD Million)
Table 84: France: Multiplex Assays Market, by Technology, 2021-2030 (USD Million)
Table 85: France: Multiplex Assays Market, by Application, 2021-2030 (USD Million)
Table 86: France: Multiplex Assays Market for Clinical Diagnosis Application, by Type, 2021-2030 (USD Million)
Table 87: France: Multiplex Assays Market, by End User, 2021-2030 (USD Million)
Table 88: U.K.: Multiplex Assays Market, by Type, 2021-2030 (USD Million)
Table 89: U.K.: Protein Multiplex Assays Market, by Type, 2021-2030 (USD Million)
Table 90: U.K.: Multiplex Assays Market, by Product, 2021-2030 (USD Million)
Table 91: U.K.: Multiplex Assays Market, by Technology, 2021-2030 (USD Million)
Table 92: U.K.: Multiplex Assays Market, by Application, 2021-2030 (USD Million)
Table 93: U.K.: Multiplex Assays Market for Clinical Diagnosis Application, by Type, 2021-2030 (USD Million)
Table 94: U.K.: Multiplex Assays Market, by End User, 2021-2030 (USD Million)
Table 95: Italy: Multiplex Assays Market, by Type, 2021-2030 (USD Million)
Table 96: Italy: Protein Multiplex Assays Market, by Type, 2021-2030 (USD Million)
Table 97: Italy: Multiplex Assays Market, by Product, 2021-2030 (USD Million)
Table 98: Italy: Multiplex Assays Market, by Technology, 2021-2030 (USD Million)
Table 99: Italy: Multiplex Assays Market, by Application, 2021-2030 (USD Million)
Table 100: Italy: Multiplex Assays Market for Clinical Diagnosis Application, by Type, 2021-2030 (USD Million):
Table 101: Italy: Multiplex Assays Market, by End User, 2021-2030 (USD Million)
Table 102: Spain: Multiplex Assays Market, by Type, 2021-2030 (USD Million)
Table 103: Spain: Protein Multiplex Assays Market, by Type, 2021-2030 (USD Million)
Table 104: Spain: Multiplex Assays Market, by Product, 2021-2030 (USD Million)
Table 105: Spain: Multiplex Assays Market, by Technology, 2021-2030 (USD Million)
Table 106: Spain: Multiplex Assays Market, by Application, 2021-2030 (USD Million)
Table 107: Spain: Multiplex Assays Market for Clinical Diagnosis Application, by Type, 2021-2030 (USD Million):
Table 108: Spain: Multiplex Assays Market, by End User, 2021-2030 (USD Million)
Table 109: COVID-19 Cases in European Countries
Table 110: Rest of Europe: Multiplex Assays Market, by Type, 2021-2030 (USD Million)
Table 111: Rest of Europe: Protein Multiplex Assays Market, by Type, 2021-2030 (USD Million)
Table 112: Rest of Europe: Multiplex Assays Market, by Product, 2021-2030 (USD Million)
Table 113: Rest of Europe: Multiplex Assays Market, by Technology, 2021-2030 (USD Million)
Table 114: Rest of Europe: Multiplex Assays Market, by Application, 2021-2030 (USD Million)
Table 115: Rest of Europe: Multiplex Assays Market for Clinical Diagnosis Application, by Type, 2021-2030 (USD Million):
Table 116: Rest of Europe: Multiplex Assays Market, by End User, 2021-2030 (USD Million)
Table 117: Asia-Pacific: Multiplex Assays Market, by Country/Region, 2021-2030 (USD Million)
Table 118: Asia-Pacific: Multiplex Assays Market, by Type, 2021-2030 (USD Million)
Table 119: Asia-Pacific: Protein Multiplex Assays Market, by Type, 2021-2030 (USD Million)
Table 120: Asia-Pacific: Multiplex Assays Market, by Product, 2021-2030 (USD Million)
Table 121: Asia-Pacific: Multiplex Assays Market, by Technology, 2021-2030 (USD Million)
Table 122: Asia-Pacific: Multiplex Assays Market, by Application, 2021-2030 (USD Million)
Table 123: Asia-Pacific: Multiplex Assays Market for Clinical Diagnosis Application, by Type, 2021-2030 (USD Million):
Table 124: Asia-Pacific: Multiplex Assays Market, by End User, 2021-2030 (USD Million)
Table 125: China: Multiplex Assays Market, by Type, 2021-2030 (USD Million)
Table 126: China: Protein Multiplex Assays Market, by Type, 2021-2030 (USD Million)
Table 127: China: Multiplex Assays Market, by Product, 2021-2030 (USD Million)
Table 128: China: Multiplex Assays Market, by Technology, 2021-2030 (USD Million)
Table 129: China: Multiplex Assays Market, by Application, 2021-2030 (USD Million)
Table 130: China: Multiplex Assays Market for Clinical Diagnosis Application, by Type, 2021-2030 (USD Million):
Table 131: China: Multiplex Assays Market, by End User, 2021-2030 (USD Million)
Table 132: Japan: Multiplex Assays Market, by Type, 2021-2030 (USD Million)
Table 133: Japan: Protein Multiplex Assays Market, by Type, 2021-2030 (USD Million)
Table 134: Japan: Multiplex Assays Market, by Product, 2021-2030 (USD Million)
Table 135: Japan: Multiplex Assays Market, by Technology, 2021-2030 (USD Million)
Table 136: Japan: Multiplex Assays Market, by Application, 2021-2030 (USD Million)
Table 137: Japan: Multiplex Assays Market for Clinical Diagnosis Application, by Type, 2021-2030 (USD Million):
Table 138: Japan: Multiplex Assays Market, by End User, 2021-2030 (USD Million)
Table 139: India: Multiplex Assays Market, by Type, 2021-2030 (USD Million)
Table 140: India: Protein Multiplex Assays Market, by Type, 2021-2030 (USD Million)
Table 141: India: Multiplex Assays Market, by Product, 2021-2030 (USD Million)
Table 142: India: Multiplex Assays Market, by Technology, 2021-2030 (USD Million)
Table 143: India: Multiplex Assays Market, by Application, 2021-2030 (USD Million)
Table 144: India: Multiplex Assays Market for Clinical Diagnosis Application, by Type, 2021-2030 (USD Million):
Table 145: India: Multiplex Assays Market, by End User, 2021-2030 (USD Million)
Table 146: Rest of Asia-Pacific: Multiplex Assays Market, by Type, 2021-2030 (USD Million)
Table 147: Rest of Asia-Pacific: Protein Multiplex Assays Market, by Type, 2021-2030 (USD Million)
Table 148: Rest of Asia-Pacific: Multiplex Assays Market, by Product, 2021- 2030 (USD Million)
Table 149: Rest of Asia-Pacific: Multiplex Assays Market, by Technology, 2021-2030 (USD Million)
Table 150: Rest of Asia-Pacific: Multiplex Assays Market, by Application, 2021-2030 (USD Million)
Table 151: Rest of Asia-Pacific: Multiplex Assays Market for Clinical Diagnosis Application, by Type, 2021-2030 (USD Million)
Table 152: Rest of Asia-Pacific: Multiplex Assays Market, by End User, 2021-2030 (USD Million)
Table 153: Latin America: Multiplex Assays Market, by Country/Region, 2021-2030 (USD Million)
Table 154: Latin America: Multiplex Assays Market, by Type, 2021-2030 (USD Million)
Table 155: Latin America: Protein Multiplex Assays Market, by Type, 2021-2030 (USD Million)
Table 156: Latin America: Multiplex Assays Market, by Product, 2021-2030 (USD Million)
Table 157: Latin America: Multiplex Assays Market, by Technology, 2021-2030 (USD Million)
Table 158: Latin America: Multiplex Assays Market, by Application, 2021-2030 (USD Million)
Table 159: Latin America: Multiplex Assays Market for Clinical Diagnosis Application, by Type, 2021-2030 (USD Million):
Table 160: Latin America: Multiplex Assays Market, by End User, 2021-2030 (USD Million)
Table 161: Brazil: Multiplex Assays Market, by Type, 2021-2030 (USD Million)
Table 162: Brazil: Protein Multiplex Assays Market, by Type, 2021-2030 (USD Million)
Table 163: Brazil: Multiplex Assays Market, by Product, 2021-2030 (USD Million)
Table 164: Brazil: Multiplex Assays Market, by Technology, 2021-2030 (USD Million)
Table 165: Brazil: Multiplex Assays Market, by Application, 2021-2030 (USD Million)
Table 166: Brazil: Multiplex Assays Market for Clinical Diagnosis Application, by Type, 2021-2030 (USD Million):
Table 167: Brazil: Multiplex Assays Market, by End User, 2021-2030 (USD Million)
Table 168: Mexico: Multiplex Assays Market, by Type, 2021-2030 (USD Million)
Table 169: Mexico: Protein Multiplex Assays Market, by Type, 2021-2030 (USD Million)
Table 170: Mexico: Multiplex Assays Market, by Product, 2021-2030 (USD Million)
Table 171: Mexico: Multiplex Assays Market, by Technology, 2021-2030 (USD Million)
Table 172: Mexico: Multiplex Assays Market, by Application, 2021-2030 (USD Million)
Table 173: Mexico: Multiplex Assays Market for Clinical Diagnosis Application, by Type, 2021-203 ( USD Million)
Table 174: Mexico: Multiplex Assays Market, by End User, 2021-2030 (USD Million)
Table 175: Rest of Latin America: Multiplex Assays Market, by Type, 2021-2030 (USD Million)
Table 176: Rest of Latin America: Protein Multiplex Assays Market, by Type, 2021-2030 (USD Million)
Table 177: Rest of Latin America: Multiplex Assays Market, by Product, 2021-2030 (USD Million)
Table 178: Rest of Latin America: Multiplex Assays Market, by Technology, 2021-2030 (USD Million)
Table 179: Rest of Latin America: Multiplex Assays Market, by Application, 2021-2030 (USD Million)
Table 180: Rest of Latin America: Multiplex Assays Market for Clinical Diagnosis Application, by Type, 2021-2030 (USD Million)
Table 181: Rest of Latin America: Multiplex Assays Market, by End User, 2021-2030 (USD Million)
Table 182: Middle East & Africa: Multiplex Assays Market, by Type, 2021-2030 (USD Million)
Table 183: Middle East & Africa: Protein Multiplex Assays Market, by Type, 2021-2030 (USD Million)
Table 184: Middle East & Africa: Multiplex Assays Market, by Product, 2021- 2030 (USD Million)
Table 185: Middle East & Africa: Multiplex Assays Market, by Technology, 2021- 2030 (USD Million)
Table 186: Middle East & Africa: Multiplex Assays Market, by Application, 2021- 2030 (USD Million)
Table 187: Middle East & Africa: Multiplex Assays Market for Clinical Diagnosis Application, by Type, 2021- 2030 (USD Million)
Table 188: Middle East & Africa: Multiplex Assays Market, by End User, 2021- 2030 (USD Million)
Table 189: Recent Developments, by Company, 2020-2023

List of Figures

Figure 1: Market Ecosystem
Figure 2: Key Stakeholders
Figure 3: Research Process
Figure 4: Secondary Sources Referenced for This Study
Figure 5: Primary Research Techniques
Figure 6: Key Executives Interviewed
Figure 7: Breakdown of Primary Interviews (Supply Side & Demand Side)
Figure 8: Market Sizing and Growth Forecast Approach
Figure 9: Global Multiplex Assays Market, By Type, 2023 Vs. 2030 (USD Million)
Figure 10: Global Multiplex Assays Market, By Product, 2023 Vs. 2030 (USD Million)
Figure 11: Global Multiplex Assays Market, By Technology, 2023 Vs. 2030 (USD Million)
Figure 12: Global Multiplex Assays Market, By Application, 2023 Vs. 2030 (USD Million)
Figure 13: Global Multiplex Assays Market, By End User, 2023 Vs. 2030 (USD Million)
Figure 14: Global Multiplex Assays Market, By Geography
Figure 15: Impact Analysis of Market Dynamics
Figure 16: Pharmaceutical R&D Expenditures in The U.S., Europe, And China, 2010 Vs. 2019 Vs. 2020 (USD Million)
Figure 17: Global Pharmaceutical R&D Expenditure, 2012-2026 (USD Billion)
Figure 18: EU Regulatory Pathway - IVDR 2017/746
Figure 19: Porter’s Five Forces Analysis
Figure 20: Global Multiplex Assays Market, By Type, 2023 Vs. 2030 (USD Million)
Figure 21: Global Multiplex Assays Market, By Product, 2023 Vs. 2030 (USD Million)
Figure 22: Global Multiplex Assays Market, By Technology, 2023 Vs. 2030 (USD Million)
Figure 23: Global Multiplex Assays Market, By Application, 2023 Vs. 2030 (USD Million)
Figure 24: U.S.: New Molecular Entity (NME) Approvals (2011-2023)
Figure 25: Estimated Number of New Cancer Cases (In Million)
Figure 26: Global Multiplex Assays Market, By End User, 2023 Vs. 2030 (USD Million)
Figure 27: Global Pharmaceutical R&D Spending, 2012-2026 (USD Billion)
Figure 28: Global Multiplex Assays Market, By Region, 2023 Vs. 2030 (USD Million)
Figure 29: North America: Number of People Aged 65 Years and Above, 2015-2021 (In Million)
Figure 30: North America: Multiplex Assays Market Snapshot
Figure 31: U.S.: Pharmaceutical R&D Expenditure, 2014-2021 (USD Billion)
Figure 32: Europe: Pharmaceutical Industry R&D Expenditure, 2000-2021 (USD Million)
Figure 33: Europe: Multiplex Assays Market Snapshot
Figure 34: U.K: Estimated Number of Cancer Cases, 2020-2030 (In Million)
Figure 35: U.K.: Number of People Diagnosed with Sexually Transmitted Infections, 2018-2020 (In Thousand)
Figure 36: Pharmaceutical R&D Expenditure, By Country, 2020 (USD Million)
Figure 37: Asia-Pacific: Multiplex Assays Market Snapshot
Figure 38: Latin America: Multiplex Assays Market Snapshot
Figure 39: Key Growth Strategies Adopted by Leading Players, 2020-2023
Figure 40: Multiplex Assays Market: Competitive Benchmarking (Based on Products)
Figure 41: Multiplex Assays Market: Competitive Benchmarking (Based on Geography)
Figure 42: Competitive Dashboard: Multiplex Assays Market
Figure 43: Seegene, Inc.: Financial Overview (2022)
Figure 44: F. Hoffmann-La Roche Ltd: Financial Overview (2022)
Figure 45: Thermo Fisher Scientific, Inc.: Financial Overview (2022)
Figure 46: Illumina, Inc.: Financial Overview (2022)
Figure 47: Qiagen N.V.: Financial Overview (2022)
Figure 48: Becton, Dickinson and Company: Financial Overview (2022)
Figure 49: Bio-Rad Laboratories: Financial Overview (2022)
Figure 50: DiaSorin S.p.A.: Financial Overview (2022)
Figure 51: PerkinElmer, Inc.: Financial Overview (2022)
Figure 52: Agilent Technologies, Inc.: Financial Overview (2022)
Figure 53: Abbott Laboratories: Financial Overview (2022)
Figure 54: Siemens Healthineers Ag: Financial Overview (2022)
Figure 55: Merck KGaA.: Financial Overview (2022)
Figure 56: Quanterix Corporation: Financial Overview (2022)

Companies Mentioned

Thermo Fisher Scientific Inc. (U.S.)
Bio-Rad Laboratories Inc. (U.S.)
Seegene Inc. (South Korea)
Qiagen N.V. (Netherlands)
PerkinElmer Inc. (U.S.)
F. Hoffmann-La Roche Ltd. (Switzerland)
Agilent Technologies Inc. (U.S.)
Abbott Laboratories (U.S.)
Siemens Healthineers AG (Germany)
Illumina Inc. (U.S.)
Becton, Dickinson and Company (U.S.)
Quanterix Corporation (U.S.)
DiaSorin S.p.A. (Italy)
Merck KGaA (Germany)